Literature DB >> 25305375

Clinical outcomes and prognostic significance of early vs. late computed tomography in acute pancreatitis.

Vishal Sharma1, Surinder S Rana2, Ravi K Sharma1, Rajesh Gupta1, Deepak K Bhasin1.   

Abstract

BACKGROUND: Guidelines recommend that contrast-enhanced computed tomography (CT) should be carried out 72 hours after onset of an attack of acute pancreatitis (AP). However, the exact time beyond 72 hours at which CT will produce the best diagnostic yield for local complications, or whether doing a CT early in acute pancreatitis has any adverse effect on the course of disease, is not clear.
METHODS: The medical records of 214 consecutive patients with AP were analysed retrospectively and these patients were divided into two groups: the early CT group (CT done at 4-5 days after the onset of pain) and the late CT group (CT done in days 6-14 following onset of pain). The two groups were compared for differences in clinical outcomes and prognostic information obtained from CT, such as detection of pancreatic necrosis and local complications, and CT severity index.
RESULTS: Of 214 patients [143 (66.8%) males; mean age 39.87 ± 13.52 years], 21 patients were excluded as they did not undergo CT or CT was done more than 14 days after onset of an attack of AP. The early CT group included 114 patients, whilst the late CT group had 79. The mean CT severity index was higher in the late CT group (6.65 ± 2.27 vs. 5.52 ± 2.7; P = 0.005). The incidence of persistent organ failure in the early group was no different from that of the late group (38.6% vs. 49.4%; P = 0.143). Local complications were detected more often in the late CT group (84.8% vs. 68.4%; P = 0.011). There was no difference between the two groups in the need for percutaneous drainage, surgery, or mortality (all P > 0.05).
CONCLUSIONS: Although performing early CT does not adversely affect the outcome in AP, CT carried out more than 5 days after the onset of symptoms may detect more local complications.
© The Author(s) 2014. Published by Oxford University Press and the Digestive Science Publishing Co. Limited.

Entities:  

Keywords:  acute pancreatitis; clinical outcomes; complications; computed tomography

Year:  2014        PMID: 25305375      PMCID: PMC4423459          DOI: 10.1093/gastro/gou067

Source DB:  PubMed          Journal:  Gastroenterol Rep (Oxf)


Introduction

Acute pancreatitis (AP) is an important gastroenterological emergency which, if severe, can lead on to a variety of local and systemic complications, a prolonged hospital course, and significant morbidity and mortality [1]. Pancreatic necrosis and peripancreatic fluid collections are the important local complications of AP and patients with pancreatic necrosis have markedly increased morbidity and mortality when compared with patients with non-necrotizing interstitial pancreatitis [2, 3]. The pancreatic necrosis is currently best detected by the loss of vascular enhancement when using cross-sectional imaging such as computed tomography (CT) or magnetic resonance imaging [1]. CT using intravenous contrast also provides an opportunity to diagnose additional pancreatic complications such as splanchnic thrombosis, extrapancreatic necrosis, ascites, pleural effusion, fluid collection and, later, walled-off necrosis/pseudocysts and pseudoaneurysms [4, 5]. However, on cross-sectional imaging, the signs of pancreatic necrosis evolve over several days, and their full extent may therefore not be completely apparent on a contrast-enhanced CT for up to 3 days after the onset of disease. Most guidelines therefore recommend that CT be done more than 72 hours after onset of symptoms. However, the development of pancreatic necrosis and local complications in AP is a dynamic process and the exact time beyond 72 hours following onset of symptoms—at which CT will show the best diagnostic yield for local complications—is not clear [1, 3, 4]. Animal studies have also shown that the intravenous contrast medium sometimes used in CT aggravates the severity of the disease by impairing pancreatic microcirculation, and these studies suggested that contrast-enhanced CT should not be performed in the early phase of acute pancreatitis [6, 7]. Experimental and clinical studies subsequently performed have both refuted and supported this claim of the detrimental effect of early CT in acute pancreatitis and this issue is still under debate [8, 9]. However, recent studies have shown that early CT does not aggravate acute pancreatitis and, on the contrary, provides important prognostic information [10, 11]. We conducted this retrospective study to compare clinical outcomes, as well as prognostic information, obtained by performing early CT (within 5 days of the onset of pain) with late CT (done 6–14 days after onset of pain).

Patients and methods

A retrospective analysis was carried out, of the collected data on the patients with AP at our unit from July 2012 to December 2013. The diagnosis of AP was established on the basis of the presence of any two of three findings (typical abdominal pain, amylase/lipase elevation at least three times normal, or consistent radiological findings) [1]. We excluded patients who did not undergo abdominal computed tomography (e.g. because of renal failure or pregnancy), patients undergoing CT more than 14 days after onset of pain or having underlying chronic pancreatitis/pancreatic malignancy. The study protocol was approved by our institute's Ethics Committee. The patients presented to us at variable times after the onset of an attack of AP and it follows that contrast-enhanced CT was carried out at correspondingly variable time points. Patients presenting within 72 hours of onset underwent CT 3 days after the attack, whereas patients presenting later underwent CT on the day of admission. The severity of disease was staged according to the Balthazar Computed Tomography Severity Index (CTSI) [4]. The demographic, clinical, laboratory and radiological data for the included patients were collected, as were details of the treatment received. The outcome was noted vis-à-vis organ failure, local complications, need for radiological/endoscopic intervention, surgery and mortality. The patients were divided into two groups: early CT group (CT done within 5 days of onset of pain), and late CT group (between days 6–14 after onset of pain). The two groups were compared for various outcome parameters, such as organ failure, local complications, need for radiological/endoscopic intervention, surgery and mortality.

Statistical analysis

The descriptive data was presented as percentages for categorical variables, and mean ± standard deviation (SD) for quantitative variables. The continuous variables were compared using student's t-test, whereas the categorical variables were compared using the Chi-squared test. A P-value of < 0.05 was considered as significant.

Results

Two hundred and fourteen consecutive patients [143 males (66.8%); mean age 39.87 ± 13.52 years) with AP were seen during the study period. The aetiology implicated in the causation of acute pancreatitis was alcohol in 88 patients (41.1%), gall stones in 62 (29.0%), both alcohol and gall stones in 14 (6.5%), idiopathic in 22 (10.3%) and other origin in 28 (13.1%). At admission, 177 (82.7%) showed evidence of systemic inflammatory response syndrome (SIRS) and the mean bedside index for severity in acute pancreatitis (BISAP) score was 2.11 ± 0.90. Of these 214 patients, 21 were excluded (CT not done in 9 patients and CT done more than 14 days after onset of attack of AP in 12) and 193 patients were included for final analysis. These were divided into two groups: the early CT group included 114 patients (77 males; mean age: 40.36 ± 14.34 years) whilst there were 79 patients in the late CT group (52 males; mean age: 40.01 ± 12.12 years). The mean timeframes in which the CT was carried out in the early and late CT groups were 3.66 ± 1.12 days and 11.78 ± 2.47 days, respectively. Demographic profiles and baseline parameters were comparable between these two groups (Table 1). There were no significant differences between the early and late CT groups in terms of age, underlying aetiology, haematological (haematocrit; leukocyte count) or biochemical parameters (blood urea; serum creatinine). The differences in clinical presentation (pain; fever and jaundice) were also not significant between the two groups, except for the frequency of the presence of mass, which was higher in the early CT group (34.2% vs. 58.2%; P = 0.001). As for parameters predicting severe acute pancreatitis, the two groups had similar SIRS (80.7% and 82.2%; P = 0.852) and mean BISAP (2.11 ± 0.94 vs. 2.09 ± 0.92; P = 0.903) at presentation. However, the mean CTSI was significantly lower in the early CT group (5.52 ± 2.7 vs. 6.65 ± 2.27; P = 0.005).
Table 1.

Comparison of demographic profile and baseline parameters between the two groups

Early CT (n = 114)Late CT (n = 79)P-value
Age (years)40.36 ± 14.3440.01 ± 12.120.863
Male, n (%)77 (67.5)52 (65.8)0.877
Aetiology, n (%)0.095
 Alcohol43 (37.7)35 (44.3)
 Gall Stones33 (28.9)23 (29.1)
Haematocrit (%)35.76 ± 8.2833.56 ± 7.350.059
Total leukocyte count (per mm3)15858 ± 664015981 ± 78260.906
Serum albumin (g/dL)3.46 ± 1.693.15 ± 0.550.120
Blood urea (mg/dL)41.7 ± 33.947.2 ± 55.60.396
Serum creatinine (mg/dL)1.16 ± 1.661.24 ± 1.590.738
Pain, n (%)113 (99.1)79 (100)1.00
Mass, n (%)39 (34.2)46 (58.2)0.001
Jaundice, n (%)7 (6.1)2 (2.5)0.313
SIRS, n (%)92 (80.7)65 (82.2)0.852
Pleural effusion, n (%)98 (85.9)70 (88.6)0.667
Ascites, n (%)66 (57.9)53 (67.1)0.175
BISAP2.11 ± 0.942.09 ± 0.920.903
CTSI5.52 ± 2.76.65 ± 2.270.005

SIRS = systemic inflammatory response syndrome; BISAP = bedside index for severity in acute pancreatitis; CTSI = computed tomography severity index

Comparison of demographic profile and baseline parameters between the two groups SIRS = systemic inflammatory response syndrome; BISAP = bedside index for severity in acute pancreatitis; CTSI = computed tomography severity index These patients were subsequently followed up and the outcome parameters compared between the two groups (Table 2). The frequency of persistent organ failure in the early CT group was no different from the late group (38.6% vs. 49.4%; P = 0.143). Local complications (acute fluid collections, as well as acute necrotic collections) were detected more often in the late group (84.8% vs. 68.4%; P = 0.011) than in the early CT group (84.8% vs. 68.4%; P = 0.011). The need for percutaneous drainage (20.2% vs. 30.3%; P = 0.125) or the need for surgery (7.0% vs.12.6%; P = 0.125) was similar in both groups. Also, there was no statistically significant difference in mortality rates between the two groups (13.1% vs.10.1%; P = 0.653).
Table 2

Comparison of outcome parameters between the two groups

Early CT (n = 114)Late CT (n = 79)P-value
Local complications, n (%)78 (68.4)67 (84.8)0.011
Persistent organ failure, n (%)44 (38.6)39 (49.4)0.143
Percutaneous drainage, n (%)23 (20.2)24 (30.3)0.125
Surgery, n (%)8 (7.0)10 (12.6)0.213
Mortality, n (%)15 (13.1)8 (10.1)0.653
Comparison of outcome parameters between the two groups

Discussion

Most guidelines recommend that contrast-enhanced CT of the abdomen be done more than 72 hours after onset of symptoms as CT carried out earlier may underestimate the extent of pancreatic necrosis. However, the development of pancreatic necrosis and local complications in AP is a dynamic process and the exact time beyond 72 hours after onset of symptoms, at which CT will show the best diagnostic yield for local complications, is not clear [1, 3, 4]. The studies have advocated a widely varying interval from the onset of acute attack to performing CT scan, ranging from 72 hours to 10 days [12, 13]. The best time to perform CT of the abdomen in AP—so that the best results are obtained for evaluating the severity of acute pancreatitis—therefore remains uncertain. In the present study, we found that CT performed more than 5 days following onset of symptoms diagnosed more local complications (acute fluid-, as well as necrotic collections, than CT done after day 3 following onset of symptoms). Also the mean CTSI was significantly higher in the late CT group than in the early group. The CTSI comprises two components: first the Balthazar grade, which also takes into account the presence of peripancreatic collections; second, the necrosis score and this difference in CTSI could be because of increased frequency of detection of acute fluid collections, as well as of necrotic collections, in the late CT group. The CTSI, a 10-point scoring system, has been shown to be an important prognostic indicator in AP [14, 15]. Although it is generally agreed that the development and extent of pancreatic necrosis are the most important indicators of disease severity in AP, one study has shown that 22% of patients with CT grades of D or E developed complications despite the absence of pancreatic necrosis [14]. Therefore, for accurate prognostication, it is important to determine both the local complications and the extent of pancreatic necrosis. Pancreatic necrosis usually develops 2–4 days after the onset of an acute attack and rarely progresses. Therefore, CT performed after 3 days would be able to delineate pancreatic necrosis accurately, but we have shown that local complications can be best detected by CT performed 5 days after the onset of an AP attack [14]. In our centre, therefore, we now do not carry out CT at admission, but 5 days after the onset of AP. There has also been speculation that injection of contrast may result in worsening of pancreatic necrosis by affecting pancreatic microcirculation: initial animal studies have indeed demonstrated that intravenous contrast medium given during CT aggravated the severity of the disease. Experimental and clinical studies performed subsequently have both refuted as well as supported this claim of detrimental effect of early CT in acute pancreatitis and this issue is still under debate [8-11]. In a report on a rat model of cerulean-induced pancreatitis, the injection of contrast seemed to increase the rates of pancreatic necrosis and mortality [6]. However in a taurocholate-induced model of experimental pancreatitis, the authors have suggested that neither ionic nor non-ionic contrasts increase pancreatic necrosis [16]. Recent clinical studies have shown that early CT does not aggravate AP and, on the contrary, provides important prognostic information [10, 11]. We also observed that early CT did not aggravate the course of AP and the outcome parameters vis-à-vis the need for percutaneous intervention, surgery and mortality were no different in the two groups. Although our study has a fairly large sample size of 193 patients but retrospective analysis and a non-randomised design are important limitations of the current study. In conclusion, although performing early CT does not adversely affect the outcome in AP, CT should be done 5 days after an attack as the frequency of detection of local complications of AP is higher than with CT done within 5 days of onset of symptoms. Conflict of interest statement: none declared.
  16 in total

Review 1.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

Review 2.  Acute pancreatitis: assessment of severity with clinical and CT evaluation.

Authors:  Emil J Balthazar
Journal:  Radiology       Date:  2002-06       Impact factor: 11.105

3.  A retrospective analysis of the effect of contrast-enhanced CT on the outcome of acute pancreatitis.

Authors:  D A McMenamin; L K Gates
Journal:  Am J Gastroenterol       Date:  1996-07       Impact factor: 10.864

4.  Contrast-enhanced dynamic computed tomography does not aggravate the clinical severity of patients with severe acute pancreatitis: reevaluation of the effect of intravenous contrast medium on the severity of acute pancreatitis.

Authors:  T L Hwang; K Y Chang; Y P Ho
Journal:  Arch Surg       Date:  2000-03

5.  Intravenous contrast medium does not increase the severity of acute necrotizing pancreatitis in the opossum.

Authors:  A M Kaiser; T Grady; D Gerdes; M Saluja; M L Steer
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

6.  Prognostic value of CT in the early assessment of patients with acute pancreatitis.

Authors:  J Darío Casas; Rocío Díaz; Gracia Valderas; Antonio Mariscal; Patricia Cuadras
Journal:  AJR Am J Roentgenol       Date:  2004-03       Impact factor: 3.959

7.  Acute pancreatitis: value of CT in establishing prognosis.

Authors:  E J Balthazar; D L Robinson; A J Megibow; J H Ranson
Journal:  Radiology       Date:  1990-02       Impact factor: 11.105

8.  Predictors of surgery in patients with severe acute pancreatitis managed by the step-up approach.

Authors:  Raghavendra Yalakanti Babu; Rajesh Gupta; Mandeep Kang; Deepak Kumar Bhasin; Surinder Singh Rana; Rajinder Singh
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

9.  Evaluation of the effects of noniodinized and iodinized ionic contrast media and gadoteric acid in acute necrotizing pancreatitis: experimental study in rabbits.

Authors:  Franz R Apodaca-Torrez; Alberto Goldenberg; Edson J Lobo; José F M Farah; Tarcisio Triviño; Edna Frasson S Montero; Vladimir Schraibman; Ricardo B Benvenuto; Ricardo Artigiani Neto
Journal:  Pancreas       Date:  2007-11       Impact factor: 3.327

10.  Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus.

Authors:  Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege
Journal:  Gut       Date:  2012-10-25       Impact factor: 23.059

View more
  2 in total

Review 1.  Paediatric pancreatitis.

Authors:  John F Pohl; Aliye Uc
Journal:  Curr Opin Gastroenterol       Date:  2015-09       Impact factor: 3.287

2.  A study of radiological scoring system evaluating extrapancreatic inflammation with conventional radiological and clinical scores in predicting outcomes in acute pancreatitis.

Authors:  Vishal Sharma; Surinder S Rana; Ravi K Sharma; Mandeep Kang; Rajesh Gupta; Deepak K Bhasin
Journal:  Ann Gastroenterol       Date:  2015 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.